Grants and Contributions:
Title:
Delivery Technology for Genetic Materials
Agreement Number:
927145
Agreement Value:
$56,000.00
Agreement Date:
Apr 1, 2019 - Sep 30, 2019
Description:
This project aims to evaluate and determine the effectiveness of a proprietary formulation in the delivery of nucleic acids and gene editing cargo into suspension cell types.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6S 1Z3
Reference Number:
172-2019-2020-Q1-927145
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
758555288
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 30 days.
Amendment Date
Aug 22, 2019
Recipient's Legal Name:
Incisive Genetics Inc.
Federal Riding Name:
Vancouver Quadra
Federal Riding Number:
59039
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: